Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety

H.A.M. Kerstjens, E. Bleecker, E. Meltzer, T. Casale, E. Pizzichini, O. Schmidt, M. Engel, L.J. Bour, C.B. Verkleij, P.M. Moroni-Zentgraf, E.D. Bateman
European Respiratory Journal 2013 42: 4629; DOI:
H.A.M. Kerstjens
1Department of Pulmonary Medicine, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Bleecker
2Center for Genomics and Personalized Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Meltzer
3Allergy & Asthma Medical Group & Research Center, San Diego, CA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Casale
4Division of Allergy and Immunology, Creighton University, Omaha, NE, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Pizzichini
5NUPAIVA (Asthma Research Centre), Universidade Federal De Santa Catarina, Santa Catarina, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
O. Schmidt
6KPPK GmbH, Koblenz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Engel
7TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L.J. Bour
8Biostatistics, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C.B. Verkleij
9Medical Department, Boehringer Ingelheim BV, Alkmaar, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P.M. Moroni-Zentgraf
7TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E.D. Bateman
10Department of Medicine, University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 42 no. Suppl 57

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online July 25, 2014.

Copyright & Usage 
© 2013 ERS

Author Information

  1. H.A.M. Kerstjens1,
  2. E. Bleecker2,
  3. E. Meltzer3,
  4. T. Casale4,
  5. E. Pizzichini5,
  6. O. Schmidt6,
  7. M. Engel7,
  8. L.J. Bour8,
  9. C.B. Verkleij9,
  10. P.M. Moroni-Zentgraf7 and
  11. E.D. Bateman10
  1. 1Department of Pulmonary Medicine, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
  2. 2Center for Genomics and Personalized Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States
  3. 3Allergy & Asthma Medical Group & Research Center, San Diego, CA, United States
  4. 4Division of Allergy and Immunology, Creighton University, Omaha, NE, United States
  5. 5NUPAIVA (Asthma Research Centre), Universidade Federal De Santa Catarina, Santa Catarina, Brazil
  6. 6KPPK GmbH, Koblenz, Germany
  7. 7TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany
  8. 8Biostatistics, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
  9. 9Medical Department, Boehringer Ingelheim BV, Alkmaar, Netherlands
  10. 10Department of Medicine, University of Cape Town, Cape Town, South Africa

Article usage

Article usage: August 2014 to April 2022

AbstractFullPdf
Aug 2014303
Sep 2014200
Oct 20149010
Nov 2014202
Dec 2014405
Jan 2015205
Feb 2015206
Mar 2015301
Apr 2015705
May 2015209
Jun 2015300
Jul 2015101
Aug 20151006
Sep 2015401
Oct 2015202
Nov 2015302
Dec 2015201
Jan 2016402
Feb 2016302
Mar 2016203
Apr 2016203
May 2016304
Jun 20165011
Jul 2016607
Aug 20161207
Sep 2016503
Oct 2016703
Nov 20161103
Dec 2016201
Jan 2017302
Feb 2017102
Mar 2017002
Apr 2017200
May 2017703
Jun 2017101
Jul 2017301
Aug 2017200
Sep 2017400
Oct 2017300
Nov 2017304
Dec 2017801
Jan 2018403
Feb 2018402
Mar 2018304
Apr 2018506
May 2018201
Jun 2018505
Jul 2018100
Aug 2018103
Sep 2018004
Oct 2018100
Nov 2018806
Jan 2019003
Feb 2019003
Mar 2019202
Apr 2019302
May 2019100
Jun 2019004
Jul 2019201
Aug 2019001
Sep 2019903
Oct 2019200
Nov 2019101
Dec 2019305
Jan 2020402
Feb 2020101
Mar 20201001
Apr 2020800
Jul 2020300
Aug 2020600
Sep 2020801
Oct 2020801
Nov 2020201
Dec 20201004
Jan 2021701
Feb 2021402
Mar 2021808
Apr 2021500
May 2021703
Jun 2021502
Jul 20211102
Aug 2021602
Sep 2021601
Oct 20211602
Nov 20212309
Dec 2021902
Jan 20221906
Feb 2022303
Mar 2022301
Apr 2022400

Altmetrics

Previous
Back to top
Vol 42 Issue Suppl 57 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety
H.A.M. Kerstjens, E. Bleecker, E. Meltzer, T. Casale, E. Pizzichini, O. Schmidt, M. Engel, L.J. Bour, C.B. Verkleij, P.M. Moroni-Zentgraf, E.D. Bateman
European Respiratory Journal Sep 2013, 42 (Suppl 57) 4629;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety
H.A.M. Kerstjens, E. Bleecker, E. Meltzer, T. Casale, E. Pizzichini, O. Schmidt, M. Engel, L.J. Bour, C.B. Verkleij, P.M. Moroni-Zentgraf, E.D. Bateman
European Respiratory Journal Sep 2013, 42 (Suppl 57) 4629;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Olodaterol attenuates bleomycin induced lung fibrosis in mice
  • Monitoring local pulmonary cAMP levels: Combining precision cut lung slice (PCLS) and fluorescence resonance energy transfer (FRET) technologies in mice
  • Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation
Show more 5.1 Airway Pharmacology and Treatment

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society